drugset / Trial / NCT01925352
Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
Phase 1/2
Unknown
40 enrolled
The First Affiliated Hospital with Nanjing Medical University
Academy Military Medical Science, China · collab
NaSingle-groupOpen-labelTreatment
Summary
To explore the safety and efficiency of adenovirus-hepatocyte growth factor(Ad-HGF) treatment in ischemic heart disease.
Timeline
- Start
- 2012-11
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ad-HGF | Unknown | 5e+09 unknown | Other |